Concepedia

Philip Bonomi

PB

Statistics

Publications

125

Citations

10.4K

H-Index

45

Active since

1978

Affiliations

Rush University Medical Center(Current)

Rush University

Presbyterian St. Luke's Medical Center

Eli Lilly (United States)

Dana-Farber Cancer Institute

Philip Bonomi is an author at Rush University Medical Center specializing in oncology, medicine, and non-small cell lung cancer therapy.

ORCID

Publications per year

1978–2025

125

Publications

125

Determinants of Tumor Response and Survival With Erlotinib in Patients With Non—Small-Cell Lung Cancer

Román Pérez-Soler, Abraham Chachoua, Lisa A. Hammond et al. · Journal of Clinical Oncology · 2004 · 1.1K citations · Full text

, , +16

Comparison of Survival and Quality of Life in Advanced Non–Small-Cell Lung Cancer Patients Treated With Two Dose Levels of Paclitaxel Combined With Cisplatin Versus Etoposide With Cisplatin: Results of an Eastern Cooperative Oncology Group Trial

Philip Bonomi, KyungMann Kim, Diane L. Fairclough et al. · Journal of Clinical Oncology · 2000 · 595 citations

, , +14

Phase II Study of Single-Agent Navitoclax (ABT-263) and Biomarker Correlates in Patients with Relapsed Small Cell Lung Cancer

Charles M. Rudin, Christine L. Hann, Edward B. Garon et al. · Clinical Cancer Research · 2012 · 551 citations · Full text

, , +17

<i>EGFR</i> -Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical Outcomes

Nicolas Marcoux, Scott Gettinger, Grainne M. O’Kane et al. · Journal of Clinical Oncology · 2018 · 471 citations

, , +17

Randomized trial of three cisplatin dose schedules in squamous-cell carcinoma of the cervix: a Gynecologic Oncology Group study.

Philip Bonomi, John A. Blessing, Frederick B. Stehman et al. · Journal of Clinical Oncology · 1985 · 406 citations

, , +15

1–5 of 125